COLORADO SPRINGS, Colo., The Spectranetics Corporation (NASDAQ:SPNC) today announced receipt of U.S. Food and Drug Administration (FDA) 510(k) clearance of its peripheral atherectomy product, the ...
COLORADO SPRINGS, Colo.--(BUSINESS WIRE)--Spectranetics Corporation (Nasdaq:SPNC) today reported that it has received clearance from the Food and Drug Administration (FDA) to market the Turbo-Tandem™, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback